Background: Intracellular accumulation of tau tangles in the brain is one of the most prominent manifestations of Alzheimer's disease (AD). Progression thereof across the AD stages has specific temporal and spatial patterns, wherein time is informative of space and vice versa. Here we introduce a novel method, Manifold Component Analysis (MCA), to represent tangle accumulation in 2D, reflecting the spatial aspect of tau propagation stages to further relate it to the temporal aspect thereof.
Method: MCA represents a neuroinformatics technique serving to smooth out transitions between neighbouring Braak stage regions (Fig. 1A) and thus creating "sub-stages" (Fig. 1B) which are subsequently used to sample neocortical (tau tangle) data and represent them in a continuous 2D graph with the spatially earliest sub-stage appearing in the leftmost, and the latest spatial sub-stage appearing on the right (Fig. 1C). This method was applied to 18F-MK-6240 tau PET tracer data from the TRIAD cohort (https://triad.tnl-mcgill.com/; N = 753; 123 AD, 170 MCI, 416 cognitively unimpaired).
Result: We obtained MCA profiles of tau-PET for each subject in the cohort, and evaluated them across multiple visits (Fig. 1D; mean inter-visit interval 1.9 years), showing that the largest change (about 25%) occurs at stages 4 and 5. Partial correlations between sub-stages within the MCA profiles for each subject, and their corresponding neuropsychological assessment measurements showed unique spatial signatures for each specific cognitive test, generally favouring earlier stage correlations for memory, and later stage correlations for higher cognition (Fig. 1E); the covariates included age, sex, APOEe4 status and years of education.
Conclusion: The MCA method proves useful as an intuitive lookup tool for tau tangle accumulation across the brain in AD. The obtained profiles help resolve correspondence between "space" and "time" contexts of the pathology spread, as well as the spatial aspect of the timeline of cognitive decline. As MCA is a subject-specific, easily applicable, fast and extensible technique, numerous new applications and extensions will follow, providing a necessary aid in staging, forecasting, and potentially treating AD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.092616 | DOI Listing |
Metab Brain Dis
January 2025
Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, 530000, China.
Alzheimer's disease (AD) is a neurodegenerative disease that primarily affects the elderly population and is the leading cause of dementia. Meanwhile, the vascular hypothesis suggests that vascular damage occurs in the early stages of the disease, leading to neurodegeneration and hindered waste clearance, which in turn triggers a series of events including the accumulation of amyloid plaques and Tau protein tangles. Non-coding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs), have been found to be involved in the regulation of AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Alzheimers Dement
December 2024
Department of Cell Biology and Pathology, New York, NY, USA.
Background: Possession of the APOE4 allele is the strongest genetic risk factor for developing the sporadic form of Alzheimer's disease (AD). Studies investigating APOE4's associated AD risk have largely centered on APOE4's propensity to regulate the deposition of extracellular amyloid beta plaques. More recent attempts to characterize APOE4's role in AD have brought into question the role APOE4 may possess in modulating the pathogenesis of intracellular tau tangles.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Brain Research Institute, Niigata University, Niigata, Niigata, Japan.
Background: Recent single-cell omics analyses have revealed that microglia change into reactive microglia when Aβ accumulates in the brain and exhibit Aβ phagocytosis. However, reactive microglia are less likely to be induced in TREM2 mutation carriers. This microglia-centred pathological mechanism may be considered one of the pathologies of AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background: We previously discovered that Aβ accumulates in the cortical/supranuclear region of the lens in people with Alzheimer's Disease (AD) (Goldstein et al., 2003) and Down Syndrome (DS; (Moncaster et al., 2010).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!